
The role of heparan sulfate as determining pathogenic factor in complement factor H-associated diseases
Keywords: FH, complement factor H; HS, heparan sulfate; AP, alternative pathway; CCP, complement control protein domain; GAG, glycosaminoglycan; AMD, age-related macular degeneration; DDD, dense deposit disease; aHUS, atypical hemolytic uremic syndrome; dpX, degree